Prospective observational study for advanced lung cancer with interstitial lung disease - Advanced lung cancer with interstitial lung disease

Among 124 patients enrolled, 109 patients who received chemotherapy were analyzed. After registration, 23 patients developed AE-ILD. The logistic analysis revealed that lower %FVC significantly increased the risk of AE-ILD. Overall response rates/median overall survival times in non-small-cell lung cancer and small-cell lung cancer for the first-line chemotherapy were 41%/8.9??onths and 91%/12.2??onths, respectively.